Digoxin is administered for the treatment of heart failure in addition to supraventricular arrhythmias (particularly atrial fibrillation and atrial flutter).
Therapeutic drug monitoring Suspected toxicity caution: low potassium (diuretics), thyroid disease, renal impairment or recent myocardial infarction. Contraindicated in hypertrophic cardiomyopathy, intermittent heart-block, ventricular tachycardia
|Normal||:||0.5-2.0 μg/L Target range in heart failure|
SST (gold top)
Take blood 6 hours post dose